Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Evaluation Review
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chesson, H. W.
Right arrow Articles by Varghese, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chesson, H. W.
Right arrow Articles by Varghese, B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Does Funding for HIV and Sexually Transmitted Disease Prevention Matter?

Evidence From Panel Data

Harrell W. Chesson

Centers for Disease Control and Prevention

Paul Harrison

Federal Reserve Board

Carol R. Scotton

Centers for Disease Control and Prevention

Beena Varghese

Centre for Health and Population Research

Since the onset of the AIDS epidemic, the Centers for Disease Control and Prevention (CDC) has allocated several billion dollars for the prevention of HIV and other sexually transmitted diseases (STDs) in the United States. Using state-level data from 1981 to 1998, the authors found that greater amounts of prevention funding in a given year are associated with reductions in reported gonorrhea incidence rates in subsequent years. The authors conclude that funding for STD and HIV prevention, on the whole, appears to have a discernable impact on the incidence of STDs.

Key Words: HIV • sexually transmitted diseases • gonorrhea, Centers for Disease Control and Prevention

Evaluation Review, Vol. 29, No. 1, 3-23 (2005)
DOI: 10.1177/0193841X04270613
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Psychosom. Med.Home page
D. C. D. Jarlais and S. Semaan
HIV Prevention for Injecting Drug Users: The First 25 Years and Counting
Psychosom Med, June 1, 2008; 70(5): 606 - 611.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
K. A. Workowski, S. M. Berman, and J. M. Douglas Jr.
Emerging Antimicrobial Resistance in Neisseria gonorrhoeae: Urgent Need to Strengthen Prevention Strategies
Ann Intern Med, April 15, 2008; 148(8): 606 - 613.
[Abstract] [Full Text] [PDF]

Home page
 AJPHHome page
B. P. Linas, H. Zheng, E. Losina, R. P. Walensky, and K. A. Freedberg
Assessing the Impact of Federal HIV Prevention Spending on HIV Testing and Awareness
Am J Public Health, June 1, 2006; 96(6): 1038 - 1043.
[Abstract] [Full Text] [PDF]